Full Text (PDF)
Original Article

BCG Vaccine

Ninza Rawal* , Ninza Rawal* , Sunil Mhaske** , Pratap Patare*** , Liza Bulsara*

Author Information

Licence:




Pediatric Education and Research 3(4):p -, October - December 2015. | DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.3415.4

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 Tuberculosis (TB) is still responsible for 2 million deaths every year despite being a treatable airborne infectious disease. “Consumption” and “Phthisis” were terms historically used to describe TB, which was responsible for one in four deaths in the 19th century. Due to its infectious nature, chronic progression and long treatment, TB is a great burden for society. Moreover the emergence of multi-drug resistant TB and the current TB-HIV epidemic has raised even greater concern. Treating and preventing TB has become a permanent challange since the ancient times. Bacille Calmette-Guérin (BCG) is the only vaccine available today and has been used for more than 90 years with astonishing safety records. However, its efficacy remains controversial. No universal BCG vaccination policy exists, with some countries merely recommending its use and others that have implemented immunization programs. 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.3415.4

Keywords


Article Level Metrics

Last Updated

Saturday 07 February 2026, 17:18:44 (IST)


202

Accesses

0
48
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share